Publications by authors named "M Epperly"

Bacterial biotherapeutic delivery vehicles have the potential to treat a variety of diseases. This approach obviates the need to purify the recombinant effector molecule, allows delivery of therapeutics via oral or intranasal administration, and protects the effector molecule during gastrointestinal transit. Lactic acid bacteria have been broadly developed as therapeutic delivery vehicles though risks associated with the colonization of a genetically modified microorganism have so-far not been addressed.

View Article and Find Full Text PDF
Article Synopsis
  • - Radiation oncologists hesitate to treat cancer in Fanconi Anemia (FA) patients due to their inability to repair DNA strand breaks, leading to concerns about normal tissue damage during therapy.
  • - Researchers created transplantable tumors in different strains of FA mice to study the impacts of radiation and chemotherapy on cancer development and progression.
  • - The established FA tumor cell lines can serve as crucial models for testing innovative radiation therapy methods and treatment combinations tailored for radiosensitive FA patients.
View Article and Find Full Text PDF

Victims of a radiation terrorist event will include pregnant women and unborn fetuses. Mitochondrial dysfunction and oxidative stress are key pathogenic factors of fetal radiation injury. The goal of this preclinical study is to investigate the efficacy of mitigating fetal radiation injury by maternal administration of the mitochondrial-targeted gramicidin S (GS)-nitroxide radiation mitigator JP4-039.

View Article and Find Full Text PDF

• Pyroptosis, an inflammatory cell death, has been implicated in the pathogenesis of total body irradiation (TBI) so we investigated time course and cell type involvement of key mediators in a murine model. • Pyroptotic mediators were most highly expressed at day 3 post TBI with immune cells from ileum being preferentially activated. • We also investigated the effectiveness of MCC950, a potent pyroptosis inhibitor, in our murine model showing a survival benefit at 50 mg/kg regardless of sex.

View Article and Find Full Text PDF

Background/aim: There is concern that people who had COVID-19 will develop pulmonary fibrosis. Using mouse models, we compared pulmonary inflammation following injection of the spike protein of SARS-CoV-2 (COVID-19) to radiation-induced inflammation to demonstrate similarities between the two models. SARS-CoV-2 (COVID-19) induces inflammatory cytokines and stress responses, which are also common to ionizing irradiation-induced acute pulmonary damage.

View Article and Find Full Text PDF